ResMed Inc. (RMD) |
| 228.25 -1.19 (-0.52%) 09-16 16:00 |
| Open: | 228.19 |
| High: | 229.325 |
| Low: | 224.26 |
| Volume: | 1,066,860 |
| Market Cap: | 33,109(M) |
| PE Ratio: | 21.19 |
| Exchange: | New York Stock Exchange |
| Industry: | Medical - Instruments & Supplies |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 242.40 |
| Resistance 1: | 232.24 |
| Pivot price: | 228.75 |
| Support 1: | 215.80 |
| Support 2: | 179.55 |
| 52w High: | 284.87 |
| 52w Low: | 180.27 |
ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service. Its extensive product range addresses a variety of respiratory disorders, encompassing advanced medical and consumer technologies, ventilation devices, diagnostic equipment, mask systems for both clinical and personal use, headgear, and related accessories, alongside dental devices. ResMed also provides sophisticated cloud-based informatics to enhance patient management and operational efficiency. Notable software offerings in its respiratory portfolio include AirView, for remote device monitoring and setting adjustments; myAir, a personalized application designed to support sleep apnea patients with education and troubleshooting for better engagement and adherence; and U-Sleep, a compliance tracking platform for home medical equipment providers. Complementing these are connectivity modules and Propeller solutions. Furthermore, ResMed offers a robust suite of out-of-hospital software. This includes Brightree, a business management platform for various home care service providers (e.g., HME, pharmacy, infusion, orthotics, prosthetics); MatrixCare, providing care management for senior living, skilled nursing, and hospice organizations; and HEALTHCAREfirst, which supplies electronic health records, billing, coding services, and analytics for home health and hospice agencies. ResMed distributes its offerings primarily to sleep clinics, home healthcare dealers, and hospitals via a global network of distributors and a direct sales force, serving approximately 140 countries. Founded in 1989, the company's headquarters are located in San Diego, California.
| EPS | 10.440 |
| Book Value | 45.660 |
| PEG Ratio | 1.33 |
| Gross Profit | 24.125 |
| Profit Margin (%) | 26.95 |
| Operating Margin (%) | 30.86 |
| Return on Assets (ttm) | 14.0 |
| Return on Equity (ttm) | 24.3 |
Tue, 15 Sep 2026
ResMed (RMD) Stock Surges Following Upgraded Rating and Price Ta - GuruFocus
Tue, 15 Sep 2026
Resmed Inc Stock (RMD) Moved Up by 3.05% on Sep 15: A Full Analysis - TradingKey
Tue, 15 Sep 2026
Is This the Right Time to Retain Resmed Stock in Your Portfolio? - TradingView
Tue, 15 Sep 2026
ResMed stock upgraded at RBC Capital Markets (RMD:NYSE) - Seeking Alpha
Tue, 15 Sep 2026
ResMed Inc. $RMD Shares Sold by Corient Private Wealth LP - MarketBeat
Mon, 14 Sep 2026
ResMed Stock: Is RMD Underperforming the Healthcare Sector? - Yahoo Finance
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |